Skip to content

Comparing the effects of Platelet-rich plasma (PRP) with Corticosteroid injection in resistant tennis Elbow patients to non-surgical treatment

Comparing the effects of Platelet-rich plasma (PRP) with Corticosteroid injection in resistant tennis Elbow patients to non-surgical treatment

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191105045335N1
Enrollment
36
Registered
2020-05-29
Start date
2020-05-21
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lateral epicondylitis. Lateral epicondylitis

Interventions

Intervention 1: Intervention group: the injection of two mL Platelet - Rich Plasma, obtained from the patient's blood centrifuge, at the maximum tenderness point by peppering method. Intervention 2: C

Sponsors

Karaj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 70 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with lateral epicondylitis and related functional impairments after six weeks of *non - surgical care such as resting, avoiding severe activities, Behavior reform, physical therapy, Non Steroid Anti Inflammatory Drug (NSAID) In physical examination, resisted wrist extension test in forearm pronation and elbow extension, VAS score=5 or more symptoms lasting for at least 3 months

Exclusion criteria

Exclusion criteria: Age of 70 years old or more History of infectious diseases or fever in recent days History of any malignancies Diagnosed carpal tunnel syndrome or any other peripheral nerve lesions or cervical radiculopathy Systemic diseases such as ischemic heart disease, diabetes mellitus, rheumatoid arthritis or hepatitis Any bone malformations or bone injuries in humerus or elbow joint History of autoimmune diseases History of Platelet dysfunction using anti platelet medications during last 10 days or using NSAIDs during last 48 hours before injection Using steroids during last 3 weeks Hb=10 or less patients with platelet count less than 150000 History of vasovagal reaction Pregnency or breast feeding

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: before injection, 2week ,1 and 3 months after injection. Method of measurement: Visual analogue scale (VAS).;Function. Timepoint: before injection, 2week ,1 and 3 months after injection. Method of measurement: Disabilities of the Arm, Shoulder and Hand (DASH) score.

Secondary

MeasureTime frame
Side effects of injection. Timepoint: 2week,1 and 3 months after injection. Method of measurement: Clinical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Ochi Ardebili

Karaj University of Medical Sciences

lamy@chmail.ir+98 26 3350 9825

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026